Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2500
-0.0060 (-2.34%)
Nov 4, 2025, 4:00 PM EST
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $386.96 million as of November 5, 2025. Its market cap has increased by 1.36% in one year.
Market Cap
386.96M
Enterprise Value
466.21M
Revenue
1.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 386.96M, an increase of 3,660.82%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 390.01M | 7.16% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | 1.25B | 870.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 577.78M |
| CytoDyn | 330.81M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 305.39M |
| Jushi Holdings | 121.95M |